Kymera (KYMR) Form 3: Officer Reports No Holdings on 09/03/2025

Brian Adams, identified as a Director and Chief Legal Officer, submitted an Initial Statement on Form 3 for Kymera Therapeutics, Inc. (KYMR) reporting the event date 09/03/2025.

Rhea-AI Filing Summary

Brian Adams, identified as a Director and Chief Legal Officer, submitted an Initial Statement on Form 3 for Kymera Therapeutics, Inc. (KYMR) reporting the event date 09/03/2025. The filing states that no securities are beneficially owned by the reporting person at the time of this statement. The form is signed by an attorney-in-fact, Bruce Jacobs, and includes an exhibit listing a Power of Attorney. This filing notifies the market of the officer/director's initial Section 16 status while showing there is currently no direct or indirect ownership to disclose.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Brian Adams report on Form 3 for KYMR?

Brian Adams reported an Initial Statement of Beneficial Ownership dated 09/03/2025 and stated no securities are beneficially owned.

What is Brian Adams' role at Kymera Therapeutics (KYMR)?

The filing lists Brian Adams as a Director and an Officer with the title Chief Legal Officer.

Does the Form 3 show any derivative or non-derivative holdings?

No. The Form 3 explicitly states no securities are beneficially owned, and no entries appear in the non-derivative or derivative tables.

Who signed the Form 3 for Brian Adams?

The form is signed by Bruce Jacobs as Attorney-in-Fact on 09/03/2025 and references an Exhibit 24 Power of Attorney.

Why is a Form 3 filed when there are no holdings?

Filing a Form 3 records an officer/director's initial Section 16 status; the document shows current beneficial ownership is none as of the event date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 09/03/2025 - 05:00 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Adams Brian

(Last) (First) (Middle)

C/O KYMERA THERAPEUTICS, INC.

500 NORTH BEACON STREET, 4TH FLOOR

(Street)

WATERTOWN MA 02472

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
09/03/2025

3. Issuer Name and Ticker or Trading Symbol
Kymera Therapeutics, Inc. [ KYMR ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Bruce Jacobs, as Attorney-in-Fact	09/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.